Milestone Pharmaceuticals (MIST) Operating Leases (2019 - 2026)
Milestone Pharmaceuticals (MIST) posted Operating Leases of $366000.0 for Q1 2026, down 32.1% on a QoQ basis from $539000.0 in Q4 2025, and down 51.72% year-over-year from $758000.0 in Q1 2025.
Milestone Pharmaceuticals (MIST) Operating Leases (2019 - 2026) Analysis & Trends
Milestone Pharmaceuticals' Operating Leases history runs 8 years deep, the most recent figure standing at $366000.0 for Q1 2026.
- Quarterly Operating Leases fell 51.72% year-over-year to $366000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $366000.0 (down 51.72% YoY) and the FY2025 annual result came in at $539000.0, down 38.33% from the prior year.
- Operating Leases was $366000.0 for Q1 2026 at Milestone Pharmaceuticals, down from $539000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $2.1 million in Q3 2022 and bottomed at $366000.0 in Q1 2026.
- A 5-year average of $1.1 million and a median of $1.0 million in 2024 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2023 — Operating Leases soared 350.26% — and 2026, when it plunged 51.72%.
- Milestone Pharmaceuticals' Operating Leases stood at $2.0 million in 2022, then declined by 27.0% to $1.5 million in 2023, then slumped by 40.01% to $874000.0 in 2024, then plunged by 38.33% to $539000.0 in 2025, then tumbled by 32.1% to $366000.0 in 2026.
- Business Quant data shows MIST's Operating Leases at $366000.0 in Q1 2026, $539000.0 in Q4 2025, and $519000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Milestone Pharmaceuticals | 156.34 Mn | -27.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 366,000.00 |
| Dec 31, 2025 | 539,000.00 |
| Sep 30, 2025 | 519,000.00 |
| Jun 30, 2025 | 641,000.00 |
| Mar 31, 2025 | 758,000.00 |
| Dec 31, 2024 | 874,000.00 |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.16 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | 1.46 Mn |
| Sep 30, 2023 | 1.58 Mn |
| Jun 30, 2023 | 1.73 Mn |
| Mar 31, 2023 | 1.86 Mn |
| Dec 31, 2022 | 2.00 Mn |
| Sep 30, 2022 | 2.09 Mn |
| Jun 30, 2022 | 384,000.00 |
| Mar 31, 2022 | 433,000.00 |
| Dec 31, 2021 | 474,000.00 |
| Sep 30, 2021 | 512,000.00 |
| Jun 30, 2021 | 573,000.00 |